Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry


Verheugt F. W. A., Gao H., Al Mahmeed W., Ambrosio G., Angchaisuksiri P., Atar D., ...Daha Fazla

EUROPEAN HEART JOURNAL, cilt.39, sa.6, ss.464-473, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1093/eurheartj/ehx730
  • Dergi Adı: EUROPEAN HEART JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.464-473
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Aims Current atrial fibrillation (AF) guidelines discourage antiplatelet (AP) monotherapy as alternative to anticoagulants (ACs). Why AP only is still used is largely unknown.